Altimmune, Inc. (ALT) vs YD Bio Limited (YDES)

Altimmune, Inc. ALT 2.20 −6.78%
YD Bio Limited YDES 5.92 −12.17%

Altimmune, Inc. and YD Bio Limited are both Biotechnology companies. Altimmune, Inc. and YD Bio Limited are of similar size ($477.5M and $459.1M).

Metric	ALT	YDES	Biotechnology median
P/E	n/m	—	8.50
P/S	8,869.05	—	9.71
P/B	0.86	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	n/m	—	0.64
EV/Sales	2,534.11	—	9.21
Earnings yield	(35.45%)	—	(33.15%)
Free cash flow yield	(18.81%)	—	(25.50%)

Metric	ALT	YDES	Biotechnology median
Gross margin	100.00%	—	65.16%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(28.87%)	—	(56.36%)
Return on assets	(25.58%)	—	(48.04%)
Return on invested capital	(34.30%)	—	0.00%

Metric	ALT	YDES	Biotechnology median
Revenue growth (TTM)	130.00%	—	6.02%
EPS growth (last fiscal year)	25.37%	—	30.26%
Revenue growth, 5-year CAGR	(65.33%)	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ALT	YDES	Biotechnology median
Debt to equity	0.07	—	0.00
Current ratio	26.78	—	4.72
Net debt to EBITDA	2.49	—	0.96

Metric	ALT	YDES	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	ALT	YDES	Biotechnology median
Market cap	459.07m	477.48m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack